Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
19
|
pubmed:dateCreated |
1985-10-8
|
pubmed:language |
spa
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0025-7753
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
18
|
pubmed:volume |
84
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
801
|
pubmed:dateRevised |
2006-4-24
|
pubmed:meshHeading |
pubmed-meshheading:3839875-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:3839875-Hodgkin Disease,
pubmed-meshheading:3839875-Humans,
pubmed-meshheading:3839875-Mechlorethamine,
pubmed-meshheading:3839875-Prednisone,
pubmed-meshheading:3839875-Procarbazine,
pubmed-meshheading:3839875-Vincristine
|
pubmed:year |
1985
|
pubmed:articleTitle |
[MOPP therapy of Hodgkin's disease previously treated with MOPP].
|
pubmed:publicationType |
Letter
|